Final ID: 53
Hantke Guixa Ana, Vazirabad Ibrahim, Mathieu Natalia, Muskus Veitia Patricia, Brozoski Daniel, Grobe Justin, Nakagawa Pablo, Sigmund Curt
Angiotensin II vascular abnormalities in 32.5% of 3322 patients with essential hypertension(EH): Use of angiotensin II analogue, saralasin.Anderson Gunnar